Trials / Completed
CompletedNCT00029848
Obese Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study of Weight-Reducing Effect and Safety in Obese Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,045 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with Type 2 Diabetes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rimonabant (SR141716) |
Timeline
- Start date
- 2001-10-01
- Primary completion
- 2004-05-01
- Completion
- 2004-05-01
- First posted
- 2002-01-24
- Last updated
- 2009-04-20
Locations
55 sites across 11 countries: United States, Argentina, Belgium, Canada, Czechia, Finland, France, Germany, Netherlands, Poland, United Kingdom
Source: ClinicalTrials.gov record NCT00029848. Inclusion in this directory is not an endorsement.